Syntron Bioresearch, Inc.

Syntron Bioresearch, Inc. is a biotechnology and manufacturing company headquartered in the United States, founded in 1986. The company specializes in manufacturing point of care in vitro diagnostic tests and detection readers and is licensed as a Medical Device Establishment by the US FDA and the State of California Department of Health Services, with ISO certification. Many of Syntron's products are 510(k) cleared, CLIA waived, and CE marked, ensuring compliance with regulatory standards. The company's product portfolio includes rapid lateral flow immunoassays for Fertility, Drugs of Abuse, Allergy, Cancer, Infectious Diseases, and Thyroid diseases, offering rapid test results in 5-minute period. In addition to its product offerings, Syntron provides extensive OEM and CMO services, expanding its capabilities as a reliable partner in the industry. The company is committed to rapid diagnostics and POCT (Point of Care Testing) with digital and quantitative features, positioning itself as a forward-thinking player in the field. As of now, there is no publicly available information about last investment or investors. For more information about Syntron Bioresearch, Inc. and its offerings, visit their website or reach out via email at [email protected].